Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | Omipalisib | 0.01 | uM | 5 | 2500.00 | 1529.25 | 2373.00 | 3675.75 | 0.6456 | 0.4152 |
SK-BR-3 | 0 | uM | 5 | 2500.00 | 1529.25 | 3785.00 | 3675.75 | 1.0297 | 1.0468 | |
SK-BR-3 | Omipalisib | 0.0033113 | uM | 5 | 2500.00 | 1529.25 | 2928.00 | 3675.75 | 0.7966 | 0.6709 |
SK-BR-3 | Taxol | 0.1 | uM | 5 | 2500.00 | 1529.25 | 1836.00 | 3675.75 | 0.4995 | 0.1555 |
SK-BR-3 | Taxol | 0.001 | uM | 5 | 2500.00 | 1529.25 | 3387.00 | 3675.75 | 0.9214 | 0.8748 |
SK-BR-3 | Palbociclib | 3.1623 | uM | 5 | 2500.00 | 1529.25 | 2517.00 | 3675.75 | 0.6848 | 0.4827 |
SK-BR-3 | Palbociclib | 0.031623 | uM | 5 | 2500.00 | 1529.25 | 3440.00 | 3675.75 | 0.9359 | 0.8979 |
SK-BR-3 | Palbociclib | 19.9526 | uM | 5 | 2500.00 | 1529.25 | 2106.00 | 3675.75 | 0.5729 | 0.2878 |
SK-BR-3 | Omipalisib | 10 | uM | 5 | 2500.00 | 1529.25 | 1456.00 | 3675.75 | 0.3961 | -0.0381 |
SK-BR-3 | 0 | uM | 5 | 2500.00 | 1529.25 | 3613.00 | 3675.75 | 0.9829 | 0.9730 | |
SK-BR-3 | 0 | uM | 5 | 2500.00 | 1529.25 | 3332.00 | 3675.75 | 0.9065 | 0.8507 | |
SK-BR-3 | 0 | uM | 5 | 5000.00 | 1298.44 | 5477.00 | 5585.50 | 0.9806 | 0.9815 | |
SK-BR-3 | 0 | uM | 5 | 5000.00 | 1298.44 | 5573.00 | 5585.50 | 0.9978 | 0.9979 | |
SK-BR-3 | Methotrexate | 0.0016596 | uM | 5 | 5000.00 | 1298.44 | 5509.00 | 5585.50 | 0.9863 | 0.9869 |
SK-BR-3 | Methotrexate | 0.0033113 | uM | 5 | 5000.00 | 1298.44 | 5624.00 | 5585.50 | 1.0069 | 1.0065 |
SK-BR-3 | Methotrexate | 3.1623 | uM | 5 | 5000.00 | 1298.44 | 3140.00 | 5585.50 | 0.5622 | 0.5212 |
SK-BR-3 | Omipalisib | 0.031623 | uM | 5 | 5000.00 | 1298.44 | 3251.00 | 5585.50 | 0.5820 | 0.5466 |
SK-BR-3 | Palbociclib | 0.0033113 | uM | 5 | 5000.00 | 1298.44 | 5184.00 | 5585.50 | 0.9281 | 0.9304 |
SK-BR-3 | 0 | uM | 5 | 5000.00 | 1298.44 | 5604.00 | 5585.50 | 1.0033 | 1.0031 | |
SK-BR-3 | Palbociclib | 0.01 | uM | 5 | 5000.00 | 1298.44 | 4877.00 | 5585.50 | 0.8732 | 0.8752 |
SK-BR-3 | Taxol | 0.00016596 | uM | 5 | 5000.00 | 1298.44 | 5805.00 | 5585.50 | 1.0393 | 1.0370 |
SK-BR-3 | Taxol | 0.031623 | uM | 5 | 5000.00 | 1298.44 | 2877.00 | 5585.50 | 0.5151 | 0.4593 |
SK-BR-3 | Methotrexate | 0.031623 | uM | 5 | 5000.00 | 1298.44 | 5902.00 | 5585.50 | 1.0567 | 1.0531 |
SK-BR-3 | Omipalisib | 0.1 | uM | 5 | 5000.00 | 1298.44 | 3011.00 | 5585.50 | 0.5391 | 0.4912 |
SK-BR-3 | Omipalisib | 0.0016596 | uM | 5 | 5000.00 | 1298.44 | 4784.00 | 5585.50 | 0.8565 | 0.8581 |